Alcohol and the Brain: One Drink a Day Associated with Brain Shrinkage
There are many conflicting studies on how alcohol consumption can impact a person’s health, with some studies suggesting light drinking can protect against coronary heart disease and others concluding...
2 Jun 202220min
Women’s Health Month: Women and Alzheimer’s Disease
In honor of Women’s Health Month, Dr. Jessica Caldwell joins the podcast to discuss sex differences in aging and Alzheimer’s disease. She explains some of the ways women experience aging and Alzheimer...
25 Mai 202227min
Disaggregating Racial Data: How Studying Ethnic Subgroups Can Improve Research
A graduate student from the University of Wisconsin–Madison is pushing for the disaggregation of data in research to better understand how individuals from different ethnic subgroups are represented a...
27 Apr 202216min
Incorporating Cultural Knowledge: Improving Alzheimer’s Disease Research for Veterans and Native Americans
Dr. Cynthia Carlsson and Daniel A. King join the podcast to discuss some of the unique ways that Alzheimer’s disease affects Veterans and Native Americans. Their work at the Wisconsin Alzheimer’s Dise...
12 Apr 202224min
Update on Blood Tests for Alzheimer’s Disease
Research in the field of fluid biomarkers is leading to new developments in Alzheimer’s disease identification, including new tests that can predict Alzheimer’s based on biomarkers in blood. Ahead of ...
22 Mar 202232min
Harnessing the Power of Autophagy to Treat Alzheimer’s Disease
The Puglielli lab at the University of Wisconsin School of Medicine and Public Health has found a way to manipulate autophagy — a process where cells clean out damaged materials — to rid the brain of ...
11 Mar 202224min
Go with the (4D) Flow: Neuroimaging Technology Used to Study Overlap of Cerebrovascular Disease and Alzheimer’s
A recent study from Alzheimer’s disease researchers at the University of Wisconsin–Madison used neuroimaging technology called 4D Flow MRI to study the relationship between blood vessel disease and Al...
22 Feb 202228min
Breaking Down Medicare’s Proposed Decision on Aducanumab and Monoclonal Antibody Treatments
On January 11, the Centers for Medicare and Medicaid Services (CMS) announced its much-anticipated coverage proposal for monoclonal antibody treatments that target amyloid for the treatment of Alzheim...
29 Jan 202229min
